Zev A. Binder

5.4k total citations
69 papers, 1.2k citations indexed

About

Zev A. Binder is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Zev A. Binder has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 32 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Zev A. Binder's work include Glioma Diagnosis and Treatment (32 papers), CAR-T cell therapy research (22 papers) and Cancer Genomics and Diagnostics (11 papers). Zev A. Binder is often cited by papers focused on Glioma Diagnosis and Treatment (32 papers), CAR-T cell therapy research (22 papers) and Cancer Genomics and Diagnostics (11 papers). Zev A. Binder collaborates with scholars based in United States, China and Australia. Zev A. Binder's co-authors include Donald M. O’Rourke, Gary L. Gallia, MacLean P. Nasrallah, Gregory J. Riggins, Steven Brem, Marie‐Odile Parat, Arati Desai, Stephen Bagley, Yanqing Gong and Duo Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zev A. Binder

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zev A. Binder United States 22 476 475 426 283 237 69 1.2k
David Tran United States 20 528 1.1× 485 1.0× 568 1.3× 255 0.9× 167 0.7× 39 1.4k
Sergey Popov United Kingdom 20 825 1.7× 316 0.7× 358 0.8× 349 1.2× 177 0.7× 48 1.5k
George Ansstas United States 17 337 0.7× 471 1.0× 428 1.0× 181 0.6× 277 1.2× 75 1.1k
An Claes Netherlands 13 548 1.2× 354 0.7× 503 1.2× 275 1.0× 80 0.3× 17 1.3k
Daniel Stieber Luxembourg 14 696 1.5× 350 0.7× 666 1.6× 544 1.9× 120 0.5× 26 1.4k
Rolf Warta Germany 21 532 1.1× 335 0.7× 347 0.8× 324 1.1× 261 1.1× 53 1.2k
Caroline Delmas France 22 794 1.7× 408 0.9× 343 0.8× 433 1.5× 139 0.6× 37 1.4k
Nicholas A. Vitanza United States 16 443 0.9× 319 0.7× 590 1.4× 130 0.5× 145 0.6× 63 1.1k
Manuela Silginer Switzerland 16 415 0.9× 344 0.7× 361 0.8× 174 0.6× 289 1.2× 31 1.0k
Koos E. Hovinga Netherlands 11 762 1.6× 659 1.4× 606 1.4× 539 1.9× 142 0.6× 25 1.5k

Countries citing papers authored by Zev A. Binder

Since Specialization
Citations

This map shows the geographic impact of Zev A. Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zev A. Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zev A. Binder more than expected).

Fields of papers citing papers by Zev A. Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zev A. Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zev A. Binder. The network helps show where Zev A. Binder may publish in the future.

Co-authorship network of co-authors of Zev A. Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Zev A. Binder. A scholar is included among the top collaborators of Zev A. Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zev A. Binder. Zev A. Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yusha, Zhijian Zhang, Yicheng Wu, et al.. (2025). Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture model. Stem Cell Reports. 20(7). 102534–102534. 2 indexed citations
2.
Binder, Zev A., Stephen Bagley, Jessica Foster, & Donald M. O’Rourke. (2025). The development of CAR T cells for patients with CNS malignancies. Nature Reviews Clinical Oncology. 23(2). 137–150.
3.
Park, Daniel H., Pratik Bhojnagarwala, Kevin Liaw, et al.. (2024). Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells. Journal for ImmunoTherapy of Cancer. 12(12). e009604–e009604. 4 indexed citations
4.
Logun, Meghan, Stephen Bagley, Daniel Zhang, et al.. (2023). CTIM-40. EARLY RADIOGRAPHIC RESPONSE AND ENGRAFTMENT OF PHASE I FIRST-IN-HUMAN BICISTRONIC CAR T CELLS CORRELATE WITH REAL-TIME AUTOLOGOUS GBM ORGANOID CYTOLYSIS. Neuro-Oncology. 25(Supplement_5). v72–v72. 1 indexed citations
5.
Till, Jacob E., Ali Nabavizadeh, Arati Desai, et al.. (2023). BIOM-41. CITRULLINATED HISTONE H3 ELISA REVEALS NETOSIS AS A SOURCE OF PROGNOSTIC CIRCULATING CELL-FREE DNA IN GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v13–v13.
6.
Tang, Oliver Y., Zev A. Binder, Donald M. O’Rourke, & Stephen Bagley. (2023). Optimizing CAR-T Therapy for Glioblastoma. Molecular Diagnosis & Therapy. 27(6). 643–660. 3 indexed citations
7.
Willis, Elinor, Esha Banerjee, Charles‐Antoine Assenmacher, et al.. (2023). 22 Humanized NOG-EXL mice exhibit improved overall survival and less severe myeloid cell activation relative to humanized NSG-SGM3 mice. SHILAP Revista de lepidopterología. A24–A24.
8.
Tang, Oliver Y., Lifeng Tian, Rong Xu, et al.. (2022). PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. Frontiers in Immunology. 13. 872756–872756. 22 indexed citations
9.
Bonté, Pierre‐Emmanuel, Antonela Merlotti, Montserrat Carrascal, et al.. (2022). Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides. Cell Reports. 39(10). 110916–110916. 35 indexed citations
10.
Durgin, Joseph S., Radhika Thokala, Lexus R. Johnson, et al.. (2021). Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase. Molecular Therapy. 30(3). 1201–1214. 21 indexed citations
11.
Thokala, Radhika, Zev A. Binder, Yibo Yin, et al.. (2021). High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms. Frontiers in Oncology. 11. 664236–664236. 22 indexed citations
12.
Li, Hu, Xingbo Cheng, Zev A. Binder, et al.. (2021). Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Frontiers in Oncology. 11. 640910–640910. 17 indexed citations
13.
Durgin, Joseph S., Fraser Henderson, MacLean P. Nasrallah, et al.. (2021). Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma. Frontiers in Oncology. 11. 669071–669071. 54 indexed citations
14.
Huang, Menggui, Duo Zhang, Chunsheng Li, et al.. (2020). Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12(532). 106 indexed citations
15.
Binder, Zev A., Mattia Bugatti, William Vermi, et al.. (2020). Pathology of macrophage activation syndrome in humanized NSGS mice. Research in Veterinary Science. 134. 137–146. 19 indexed citations
16.
Bagley, Stephen, Seyed Ali Nabavizadeh, Jacob E. Till, et al.. (2019). Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study. Clinical Cancer Research. 26(2). 397–407. 81 indexed citations
17.
Nasrallah, MacLean P., Zev A. Binder, Derek A. Oldridge, et al.. (2019). Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma. Academic Pathology. 6. 1533848481–1533848481. 16 indexed citations
18.
Singh, Nathan, Elena J. Orlando, Jun Xu, et al.. (2019). Mechanisms of resistance to CAR T cell therapies. Seminars in Cancer Biology. 65. 91–98. 28 indexed citations
19.
Roccograndi, Laura, Zev A. Binder, Logan Zhang, et al.. (2017). SHP2 regulates proliferation and tumorigenicity of glioma stem cells. Journal of Neuro-Oncology. 135(3). 487–496. 30 indexed citations
20.
Baía, Gilson S., Otávia L. Caballero, Qi Zhao, et al.. (2013). NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches. Cancer Immunology Research. 1(5). 296–302. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Tran Breakdown of academic impact, for papers by Sergey Popov Breakdown of academic impact, for papers by George Ansstas Breakdown of academic impact, for papers by An Claes Breakdown of academic impact, for papers by Daniel Stieber Breakdown of academic impact, for papers by Rolf Warta Breakdown of academic impact, for papers by Caroline Delmas Breakdown of academic impact, for papers by Nicholas A. Vitanza Breakdown of academic impact, for papers by Manuela Silginer Breakdown of academic impact, for papers by Koos E. Hovinga
Rankless by CCL
2026